| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5887768 | Seminars in Arthritis and Rheumatism | 2014 | 5 Pages |
Abstract
Current HTN therapeutic guidelines, lacking data from large-scale clinical trials, may not adequately apply to SLE patients. The assessment of the aforementioned recommendations in randomized clinical trials is expected to confirm their value in reducing CV risk in SLE.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Konstantinos MD, PhD, Charalampos MD, Murray B. MD, FRCPC, Dafna D. MD, FRCPC,